跳至主要内容
临床试验/ACTRN12621000233820
ACTRN12621000233820尚未招募1 期

Effects on pupil size and recovery from daily and alternate-day instillation of various low-dose atropine eye drops in adults with healthy vision

SW Sydney0 个研究点目标入组 30 人开始时间: 2021年3月5日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
All

入选标准

  • 1) Normal general and ocular health
  • 2) Adults aged 18-40 years
  • 3) No allergy to atropine or preservatives
  • 4) No history or risk of glaucoma

排除标准

  • 1) Atropine eye drop use within 2 weeks prior to enrolment
  • 2) Any eye diseases including inflammation, infection or allergy
  • 3) History of allergic reaction to eye medications
  • 4) Risk of glaucoma
  • 5) Currently using any eye medications or systemic monoamine oxidase inhibitors (MAOIs)
  • 6) Women who are pregnant, planning to become pregnant or breastfeeding7) History of cardiac disease

研究者

发起方
SW Sydney

相似试验